133(top 1%)
papers
6.4K(top 1%)
citations
39(top 1%)
h-index
80(top 1%)
g-index
143
all documents
6.7K
doc citations
1.3K
citing journals

Top Articles

#TitleJournalYearCitations
1Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international studyLeukemia2013540
2Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatmentLeukemia2008443
3Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemiaBlood2007419
4Changes in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic ImplicationsAnnals of Internal Medicine2001351
5Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burdenLeukemia2007328
6Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter studyHaematologica2013268
7Clinical implications of the JAK2 V617F mutation in essential thrombocythemiaLeukemia2005236
8JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosisBlood2007233
9GATA-1 as a Regulator of Mast Cell Differentiation Revealed by the Phenotype of the GATA-1low Mouse MutantJournal of Experimental Medicine2003203
10An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasmsLeukemia2014198
11WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)Blood2008192
12Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow TransplantationJournal of Clinical Oncology2001173
13Advances in Understanding and Management of Myeloproliferative NeoplasmsCa-A Cancer Journal for Clinicians2009170
14Influence of JAK2V617F allele burden on phenotype in essential thrombocythemiaHaematologica2008146
15Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantationBlood2009131
16Molecular Profiling of CD34+Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (WT1)Stem Cells2007111
17Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective surveyBlood2008106
18Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemiaBlood2008100
19Azacitidine for the treatment of lower risk myelodysplastic syndromesCancer201098
20Bone Marrow Mesenchymal Stromal Cells Stimulate Skeletal Myoblast Proliferation through the Paracrine Release of VEGFPLoS ONE201293
21Hypermethylation ofCXCR4Promoter in CD34+ Cells from Patients with Primary MyelofibrosisStem Cells200891
22Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidineLeukemia201480
23Thrombocytosis and ThrombosisHematology American Society of Hematology Education Program200773
24MicroRNA expression profile in granulocytes from primary myelofibrosis patientsExperimental Hematology200771
25A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresisLeukemia200668
26The ‘GGCC’ haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia veraLeukemia200968
27Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplantBone Marrow Transplantation199866
28Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study GroupTransplantation200964
29Abnormalities of GATA-1 in Megakaryocytes from Patients with Idiopathic MyelofibrosisAmerican Journal of Pathology200562
30A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemiaLeukemia201858
31Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana LinfomiHaematologica201455
32Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuriaBlood200754
33The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patientsLeukemia200651
34Insights into JAK2-V617F mutation in CMLLancet Oncology, The200750
35Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses groupBone Marrow Transplantation200750
36Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemiaAmerican Journal of Hematology201048
37HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor RegistryBone Marrow Transplantation200948
38Safety of Bone Marrow Stem Cell Donation: A ReviewTransplantation Proceedings201046
39Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort studyLancet Haematology,the201844
40A Phase I Study of the Proteasome Inhibitor Bortezomib in Patients with Myelofibrosis.Blood200739
41Characterization and discovery of novel miRNAs and moRNAs in JAK2V617F-mutated SET2 cellsBlood201234
42Epstein–Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantationLeukemia and Lymphoma200633
43Percutaneous vertebroplasty and kyphoplasty in patients with multiple myelomaEuropean Journal of Haematology200632
44A Phase 2 Study of INCB018424, An Oral, Selective JAK1/JAK2 Inhibitor, in Patients with Advanced Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Refractory to Hydroxyurea.Blood200929
45Comparative Proteomic Analysis of Chronic Myelogenous Leukemia Cells:  Inside the Mechanism of Imatinib ResistanceJournal of Proteome Research200728
46Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issuesLeukemia200927
47Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life studyBone Marrow Transplantation202127
48Searching for the Magic Bullet Against Cancer: The Butyrate SagaLeukemia and Lymphoma200126
49Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B‐cell lymphomas and comparison with the commonly used therapiesEuropean Journal of Haematology200926
50Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia veraBlood201126